the next generation of pharmaceutical innovation

The next generation of pharmaceutical innovation

Rebecca Sykes, Global Industry Analyst
2023-09-30
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

The views expressed are those of the author at the time of writing. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional, institutional, or accredited investors only.

I think looking more broadly at the whole health care ecosystem — across subsectors of biopharmaceuticals, medical devices, and health care services — it's a really great time for dedicated health care analysts to research companies and build portfolios for clients.

Rebecca Sykes
Global Industry Analyst

Expert

Related insights

Showing of Insights Posts
Biotech's new frontier Continue reading
event
Video
2023-09-30
The power of capital to drive change Continue reading
event
Article
2023-10-31
Fintech innovation: A pure play on enduring disruption Continue reading
event
Article
2023-09-30

Read next